News

TipRanks on MSN14h
Akari Therapeutics initiated with a Buy at Maxim
Maxim analyst Jason McCarthy initiated coverage of Akari Therapeutics (AKTX) with a Buy rating and $5 price target Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! ...
Man arrested, charged with possession of ‘Glock switch’ in Northport shooting
Authorities in Northport and Tuscaloosa County say a man has been arrested on charges of possessing a ‘Glock switch’ under a ...
Akari Therapeutics Insiders Added US$1.79m Of Stock To Their Holdings
Multiple insiders secured a larger position in Akari Therapeutics, Plc ( NASDAQ:AKTX ) shares over the last 12 ...
GMA Network3d
PVL: Akari mounts huge Set 3 comeback to complete sweep win vs. Capital1
Akari crawled back from eight points down in the third set en route to a 25-23, 25-18, 25-23 win against Capital1 in the 2025 ...
Yahoo Finance4mon
Akari Therapeutics Announces $7.6 Million Private Placement Offering ...
Akari Therapeutics Plc. BOSTON and LONDON, March 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional ...